4/A//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4/A
Accession 0001465825-15-000002
$ELTPCIK 0001053369operating
Filed
May 20, 8:00 PM ET
Accepted
May 21, 2:42 PM ET
Size
5.4 KB
Accession
0001465825-15-000002
Insider Transaction Report
Form 4/AAmended
NIGALAYE ASHOK G
DirectorChief Scientific Officer10% Owner
Transactions
- Other
Common Stock
2015-04-23+19,275,135→ 36,442,232 total
Footnotes (3)
- [F1]Disposition of common stock to its members.
- [F2]Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which was a 10% owner of the issuer, and also serves as a director of the issuer. Reporting person received these securities pursuant to a distribution by EI to members of Epic Pharma, LLC.
- [F3]In the original filing, there was an addition error in the total number of shares owned. This amended filing corrects the total number of shares beneficially owned.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4/A
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 2:42 PM ET
- Size
- 5.4 KB